Dihydroartemisinin promotes neurological rehabilitation after ischemic stroke by targeting TAK1-CREB1 signaling pathway to inhibit ferroptosis.
- DOI
- 10.1016/j.molimm.2026.07.012
- Published
- 2026 Sep
- Container
- Molecular immunology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.molimm.2026.07.012,
title = {Dihydroartemisinin promotes neurological rehabilitation after ischemic stroke by targeting TAK1-CREB1 signaling pathway to inhibit ferroptosis.},
author = {Ye S and Bao L and Xu Q and Ding Z and Wu F and Yuan X and Zhou Y and Amin N and Sundus J and Fang M},
year = {2026},
journal = {Molecular immunology},
doi = {10.1016/j.molimm.2026.07.012},
url = {https://doi.org/10.1016/j.molimm.2026.07.012}
}RIS
TY - JOUR TI - Dihydroartemisinin promotes neurological rehabilitation after ischemic stroke by targeting TAK1-CREB1 signaling pathway to inhibit ferroptosis. AU - Ye S AU - Bao L AU - Xu Q AU - Ding Z AU - Wu F AU - Yuan X AU - Zhou Y AU - Amin N AU - Sundus J AU - Fang M PY - 2026 JO - Molecular immunology DO - 10.1016/j.molimm.2026.07.012 UR - https://doi.org/10.1016/j.molimm.2026.07.012 ER -
APA
S, Y., L, B., Q, X., Z, D., F, W., X, Y., Y, Z., N, A., J, S., & M, F. (2026). Dihydroartemisinin promotes neurological rehabilitation after ischemic stroke by targeting TAK1-CREB1 signaling pathway to inhibit ferroptosis.. Molecular immunology. https://doi.org/10.1016/j.molimm.2026.07.012
Source records
- pubmed · retrieved 2026-09-25T23:30:13.189Z